IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Preclinical biotech developing FGFR kinase inhibitors for solid tumors.
Industry: Health Care
Latest Trade: $18.53 0.00 (0.0%)
First Day Return: +62.5%
Return from IPO: +15.8%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 08/20/2021 |
Offer Price | $16.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 10.8 |
Deal Size ($mm) | $173 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 09/14/2021 |
Offer Price | $16.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 10.8 |
Deal Size ($mm) | $173 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
BofA Securities |
Jefferies |
more |
Company Data | |
---|---|
Headquarters | Carlsbad, CA, United States |
Founded | 2018 |
Employees | 18 |
Website www.tyra.bio |